Search - health

 
 
Japan Times
WORLD / Science & Health
Oct 19, 2021

What scientists know about the risk of breakthrough COVID-19 deaths

After former U.S. Secretary of State Colin Powell died Monday from COVID-19 complications, vaccine skeptics immediately seized on news that he had been vaccinated to stoke doubts.
JAPAN
Oct 10, 2021

Osaka eases COVID-19 vaccine reservation requirement to speed up inoculations ahead of next wave

Although infections have been declining in both Tokyo and Osaka, the daily tally in Osaka started to exceed that of Tokyo late last month.
Japan Times
WORLD / Science & Health / FOCUS
Oct 7, 2021

A Chilean tree holds hope for new vaccines — if supplies last

Quillay trees, technically known as Quillaja saponaria, are rare evergreens native to Chile that have long been used by the indigenous Mapuche people to make soap and medicine.
Japan Times
TENNIS
Sep 15, 2021

Emma Raducanu's toughest challenge is coping with the fame game

The experiences of other women who have made their breakthroughs on the game's biggest stage in recent years illustrate that sudden fame can be a mixed blessing.
Japan Times
COMMENTARY / World
Sep 14, 2021

The U.K.’s bizarre $1.7 billion vaccine rug-pull

The British government abruptly canceled its supply contract, having found Valneva in breach of its obligations without specifying how — something Valneva contests.
Japan Times
WORLD
Sep 13, 2021

What will the next six months of the pandemic bring?

With billions of people around the world yet to be vaccinated and little chance now of eliminating the virus, we can expect more outbreaks over the coming months.
Japan Times
JAPAN
Sep 8, 2021

Japan prioritized domestic trials of Pfizer before rollout, vaccine czar says

The nation's vaccine czar revealed that Pfizer trials included over 100 Japanese residents in the U.S., but said the health ministry needed domestic tests due to 'food and diet' differences.
Japan Times
BUSINESS / Companies
Sep 8, 2021

Medical-device maker PHC planning ¥172 billion IPO, Japan's biggest since 2018

This year about $3.4 billion has been raised through Japanese IPOs, a huge increase from the $804 million garnered in the same period in 2020, data shows.
Japan Times
WORLD
Sep 3, 2021

Lawmakers probe ‘anomalies’ in approval of Biogen Alzheimer’s drug

The congressional inquiry adds to pressure on the U.S. agency charged with regulating products that account for one-fifth of consumer spending.
Japan Times
COMMENTARY / World
Sep 2, 2021

COVID-19 vaccines may become a viable business. That’s a problem.

Inoculations have been distributed to almost every person on the planet. But, traditionally, they been unprofitable for the pharmaceutical industry.
Japan Times
COMMENTARY / World
Aug 29, 2021

New treatment emerges amid COVID-19 vaccine efficacy concerns

With studies showing COVID-19 vaccine efficacy declining faster than expected, boosters aren't the only option, and in some cases they may not even be the best.
Japan Times
COMMENTARY / World
Aug 19, 2021

Singapore's social divisions aren't so clear cut

COVID-19 didn't create the city's economic and social anxieties, but it brought them to the surface.
Japan Times
COMMENTARY / World
Aug 13, 2021

A more infectious COVID-19 needs a quicker test

The now-dominant COVID-19 delta variant spreads so quickly that every missed opportunity to catch an infectious person can lead to many more new cases.
Japan Times
COMMENTARY / World
Aug 12, 2021

Apocalypse soon? Let's hope it's not too late.

Dramatic changes such as climate change, disease outbreaks and food shortages are occurring and we must hope that it is not yet too late to address them.
Japan Times
COMMENTARY / World
Aug 12, 2021

Can Moderna buy its way into the $200 billion club?

Moderna's COVID-19 windfall sees its market valuation surged by more than $100 billion since May.
Japan Times
COMMENTARY / World
Jul 30, 2021

Legitimate pain research is more crucial than ever

Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.
Japan Times
WORLD / Science & Health
Jul 29, 2021

Doctors blast Biogen Alzheimer approval as ‘regulatory failure’

The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency's decision.
Japan Times
COMMENTARY / World
Jul 26, 2021

London’s delta surge should jolt New York

A big question is whether New York, another large city that has reopened after having been through the COVID-19 wringer in 2020, will face a similar resurgence of cases like London.
Japan Times
Rugby
Jul 22, 2021

Half of elite rugby players showed changes in brain volume, concussion study finds

Head injuries and their potential long-term health impact have been in the spotlight since former players filed a class-action lawsuit against governing bodies.
Japan Times
COMMENTARY / World
Jul 19, 2021

Latest U.S. Alzheimer's drug fix is a patch job

Most of the FDA's decisions don't receive national attention, which means they may not be rectified until substantial harm is done.
Japan Times
BUSINESS / Companies
Jul 13, 2021

Eisai pushes second Alzheimer's drug despite call to probe U.S. approval of first

The U.S. Food and Drug Administration's June approval of Aduhelm caused resignations among a panel of independent experts who said the therapy was ineffective.

Longform

Koichi Tagawa’s diary entry from Aug. 9, 1945, describes the day of the atomic bombing of Nagasaki.
The horrors of Nagasaki, in first person